IL-2 induces in vivo suppression by CD4+
✍
Susan Brandenburg; Takeshi Takahashi; Maurus de la Rosa; Marko Janke; Gabriele K
📂
Article
📅
2008
🏛
John Wiley and Sons
🌐
English
⚖ 403 KB
## Abstract Interleukin‐2 (IL‐2) treatment is currently used to enhance T cell‐mediated immune responses against tumors or in viral infections. At the same time, IL‐2 is essential for the peripheral homeostasis of CD4^+^CD25^+^Foxp3^+^ regulatory T cells (Treg). In our study, we show that IL‐2 is a